(Begin-Sadat Center for Strategic Studies-Bar-Ilan University) Dr. Frank Musmar - The Israeli drug giant Teva has announced that 6 million doses of hydroxychloroquine will be delivered to U.S. hospitals by March 31. Teva indicated that it will do everything possible to accelerate production of hydroxychloroquine and also conduct research to see if, in its vast catalog of 3,500 drugs, others can be used to fight coronavirus. Another Israeli drug cited as possibly helpful is remdesivir, an experimental antiviral from Gilead Sciences. The writer is a financial and performance management specialist and a non-resident associate at the BESA Center.
2020-03-26 00:00:00Full ArticleBACK Visit the Daily Alert Archive